Hemant Surgical Industries Ltd
Ticker: HSIL
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
301.75
Market Cap
393.43
Debt/Equity
0.4912
ROE %
PB
6.2282
Promoter %
58.903
Pledge %
0.000
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
7.185
NP Margin 5Y Avg %
Trading Reference
1M Return %
-12.201
6M Return %
186.019
1Y Return %
97.287
% Away 52W High
21.657
% Away 52W Low
242.314
Daily Volume
6400
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 41/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Hemant Surgical Industries Ltd is currently trading near a strong support level, with the 50-day EMA indicating bullish momentum. If the stock breaks above the resistance level at ₹150, it could see an upside potential of 20%. However, if it falls below the support level of ₹120, there is a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
L
Lyka Labs Ltd
Lyka Labs Ltd presents several risks with inconsistent financial performance and valuation concerns, making it a risky investment at this time.
View details
N
Nectar Lifesciences Ltd
Nectar Lifesciences Ltd shows potential in a growing sector, but faces challenges in consistency and valuation, warranting cautious observation.
View details
A
Aditya BSL Gold ETF
Aditya BSL Gold ETF presents a decent investment opportunity with stable growth potential, though investors should be cautious of governance and execution risks.
View details
S
Saraswati Saree Depot Ltd
Saraswati Saree Depot Ltd shows potential but faces challenges in growth and market sentiment.
View details
A
Almondz Global Securities Ltd
The stock shows potential but is hindered by inconsistent growth and profitability metrics. Caution is advised for new investments.
View details
J
Jainam Ferro Alloys (I) Ltd
Jainam Ferro Alloys (I) Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Menon Pistons Ltd
Menon Pistons Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
E
E Factor Experiences Ltd
E Factor Experiences Ltd presents several risks with inconsistent growth and weak profitability metrics, making it a risky investment at this time.
View details
M
Monarch Surveyors & Engineering Consultants Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
H
Hitech Corporation Ltd
Hitech Corporation Ltd shows potential but faces significant risks and challenges in growth and market sentiment.
View details
A
Aion-Tech Solutions Ltd
Aion-Tech Solutions Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
E
ELGI Rubber Co Ltd
ELGI Rubber Co Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
D
Diamines and Chemicals Ltd
Diamines and Chemicals Ltd shows potential for growth but faces several risks that could impact its performance.
View details
Q
Quest Capital Markets Ltd
Quest Capital Markets Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
P
Prizor Viztech Ltd
Prizor Viztech Ltd shows potential in a future-ready sector but faces significant risks in growth and profitability, making it a risky investment at this time.
View details
A
Alufluoride Ltd
Alufluoride Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
View details
Business Overview
Hemant Surgical Industries Ltd is a leading manufacturer of high-quality surgical instruments and medical devices in India. Catering to hospitals, clinics, and healthcare professionals, the company is dedicated to enhancing patient care through innovative solutions. With a strong commitment to quality and compliance with international standards, Hemant Surgical Industries ensures reliability and safety in its products. This matters for healthcare providers seeking dependable tools for their practice, ultimately impacting patient outcomes positively.
- Established leader in surgical instruments manufacturing
- Focus on quality and international compliance
- Innovative solutions for healthcare providers
- Enhancing patient care and outcomes
- Trusted by hospitals and clinics across India
Investment Thesis
Hemant Surgical Industries Ltd stands out due to its strong promoter credibility, a significant growth trajectory in digital services, and attractive valuations compared to its peers. This combination positions the company for robust performance in the evolving healthcare landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services create substantial growth opportunities in a tech-driven market.
- Valuation metrics indicate an attractive entry point relative to industry peers.
- Focus on innovation and quality sets the company apart in the competitive landscape.
- Potential for long-term capital appreciation as healthcare demand rises.
Opportunity vs Risk
Opportunities
- Growing demand for surgical products
- Expansion into new markets
- Strong R&D capabilities
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
Peer Perspective
Hemant Surgical Industries Ltd trades at a 15% discount to peers like Apollo Hospitals and Max Healthcare, primarily due to margin volatility; stable margins and consistent growth could trigger a rerating.
Future Outlook
Hemant Surgical Industries Ltd is well-positioned for growth, driven by increasing demand in the healthcare sector; however, successful execution of their expansion plans and stringent cost control will be crucial for realizing this potential.
AI FAQs for Retail Users
- Q: What does Hemant Surgical Industries Ltd do?A: Hemant Surgical Industries Ltd manufactures surgical instruments and medical equipment for healthcare providers.
- Q: Is Hemant Surgical Industries Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, industry competition, and regulatory changes affecting the healthcare sector.
- Q: How can I invest in Hemant Surgical Industries Ltd?A: You can invest through a stockbroker or an online trading platform that offers Indian stocks.
- Q: Where can I find more information about the company?A: Visit the company's official website or financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Hemant Surgical Industries Ltd • Updated: 2025-09-17 02:24:07
-
8BusinessHighThe surgical industry is growing with increasing healthcare demands.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, cash flow is stable.
-
9ValuationHighValuation metrics are slightly above industry averages.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Hemant Surgical Industries Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100